Biochips Market by Type (DNA Chip (Genomics, Drug Discovery, Gene Expression) Lab-on-a-chip (IVD & POC, Proteomics), Protein Chips), End user (Academics Institutes, Diagnostics Centers), Fabrication Technology (Microarrays, Microfluidics) - Forecast to 2020
Growing Applications of Biochips and Technological Advancements Will Boost the Growth of the Biochips Market
The biochips market is expected to reach USD 17.75 billion by 2020 from USD 7.63 billion in 2015, growing at a CAGR of 18.4% during the forecast period (2015–2020). A biochip is an assembly of miniaturized test sites arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput.
In this report, the biochips market is segmented on the basis of type, application, fabrication technology, end user, and region. Based on type, the market is segmented into DNA chips, lab-on-a-chip, protein chips, and other arrays. The other arrays segment includes cell arrays and tissue arrays.
Based on end users, the biochips market is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories). Similarly, based on fabrication technology, the biochips market is segmented into microarrays and microfluidics.
Increasing adoption of personalized medicine, growing applications of biochips, and technological advancements are the major drivers for the biochips market. However, unclear regulatory guidelines, high instrumentation costs, and absolute quantification of specific mRNA may restrain the market growth to a certain extent. On the other hand, developing countries are expected to offer significant growth opportunities for players operating in the biochips market.
PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) are the major players in the biochips market.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the biochips market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
The biochips market is expected to reach USD 17.75 billion by 2020 from USD 7.63 billion in 2015, growing at a CAGR of 18.4% during the forecast period (2015–2020). A biochip is an assembly of miniaturized test sites arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput.
In this report, the biochips market is segmented on the basis of type, application, fabrication technology, end user, and region. Based on type, the market is segmented into DNA chips, lab-on-a-chip, protein chips, and other arrays. The other arrays segment includes cell arrays and tissue arrays.
Based on end users, the biochips market is categorized into four major segments, namely, hospitals & diagnostic centers, biotechnology & pharmaceutical companies, academic & research institutes, and other end users (blood banks, CROs, forensic labs, point-of-care settings, home health agencies, nursing homes, and local public health laboratories). Similarly, based on fabrication technology, the biochips market is segmented into microarrays and microfluidics.
Increasing adoption of personalized medicine, growing applications of biochips, and technological advancements are the major drivers for the biochips market. However, unclear regulatory guidelines, high instrumentation costs, and absolute quantification of specific mRNA may restrain the market growth to a certain extent. On the other hand, developing countries are expected to offer significant growth opportunities for players operating in the biochips market.
PerkinElmer Inc. (U.S.), Fluidigm Corporation (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Cepheid Inc. (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) are the major players in the biochips market.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the biochips market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on products offered by the top players in the global biochips market
- Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the biochips market
- Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for biochips across various regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global biochips market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the biochips market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKETS SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.3 KEY INDUSTRY INSIGHTS
2.2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 BIOCHIPS MARKET OVERVIEW
4.2 BIOCHIPS MARKET: BY APPLICATION AND END USER
4.3 BIOCHIPS MARKET: GEOGRAPHIC SNAPSHOT
4.4 BIOCHIPS MARKET: BY TYPE
4.5 BIOCHIPS MARKET: BY END USER
4.6 BIOCHIPS MARKET: BY FABRICATION TECHNOLOGY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 BY TYPE AND APPLICATION
5.2.2 BY FABRICATION TECHNOLOGY
5.2.3 BY END USER
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Increasing adoption of personalized medicine
5.3.1.2 Growing applications of biochips
5.3.1.3 Technological advancements
5.3.2 RESTRAINTS
5.3.2.1 Unclear regulatory guidelines
5.3.2.2 High instrumentation costs
5.3.2.3 Absolute quantification of specific mRNA expressions
5.3.3 OPPORTUNITIES
5.3.3.1 Significant growth prospects in developing countries
5.3.3.2 Biochip technology, a safe and economical alternative to animal testing
5.3.4 CHALLENGES
5.3.4.1 Complexity of biological systems
6 BIOCHIPS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 DNA CHIPS
6.2.1 DNA CHIPS MARKET, BY APPLICATION
6.2.1.1 Gene expression
6.2.1.2 SNP Genotyping
6.2.1.3 Cancer Diagnosis & Treatment
6.2.1.4 Genomics
6.2.1.5 Drug Discovery
6.2.1.6 Agricultural Biotechnology
6.2.1.7 Other DNA Chip Applications
6.3 LAB-ON-A-CHIP
6.3.1 LAB-ON-A-CHIP MARKET, BY APPLICATION
6.3.1.1 Clinical Diagnostics
6.3.1.2 Genomics
6.3.1.3 IVD & POC
6.3.1.4 Proteomics
6.3.1.5 Drug Discovery
6.3.1.6 Other LOAC Applications Market
6.4 PROTEIN CHIPS
6.4.1 PROTEIN CHIPS MARKET, BY APPLICATIONS
6.4.1.1 Proteomics
6.4.1.2 Expression Profiling
6.4.1.3 Diagnostics
6.4.1.4 High-throughput Screening
6.4.1.5 Drug Discovery
6.4.1.6 Other Applications
6.5 OTHER ARRAYS
6.5.1 CELL ARRAYS
6.5.2 TISSUE ARRAYS
7 BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY
7.1 INTRODUCTION
7.2 MICROARRAYS
7.3 MICROFLUIDICS
8 BIOCHIPS MARKET, BY END USER
8.1 INTRODUCTION
8.2 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
8.3 HOSPITALS AND DIAGNOSTICS CENTERS
8.4 ACADEMIC & RESEARCH INSTITUTES
8.5 OTHERS
9 BIOCHIPS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.3 EUROPE
9.4 ASIA-PACIFIC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE SITUATION AND TRENDS
10.2.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.2.2 ACQUISITIONS
10.2.3 PRODUCT LAUNCHES AND ENHANCEMENTS
10.2.4 EXPANSIONS
10.2.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Overview, Financial*, Products & Services, Strategy, and Developments)
11.1 INTRODUCTION
11.2 ABBOTT LABORATORIES
11.3 AGILENT TECHNOLOGIES, INC.
11.4 PERKINELMER, INC.
11.6 FLUIDIGM CORPORATION
11.7 ILLUMINA, INC.
11.8 GE HEALTHCARE
11.9 BIO-RAD LABORATORIES INC.
11.10 CEPHEID INC.
11.12 THERMO FISHER SCIENTIFIC, INC.
11.13 ROCHE DIAGNOSTICS
*Details might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKETS SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.3 KEY INDUSTRY INSIGHTS
2.2.4 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 BIOCHIPS MARKET OVERVIEW
4.2 BIOCHIPS MARKET: BY APPLICATION AND END USER
4.3 BIOCHIPS MARKET: GEOGRAPHIC SNAPSHOT
4.4 BIOCHIPS MARKET: BY TYPE
4.5 BIOCHIPS MARKET: BY END USER
4.6 BIOCHIPS MARKET: BY FABRICATION TECHNOLOGY
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 BY TYPE AND APPLICATION
5.2.2 BY FABRICATION TECHNOLOGY
5.2.3 BY END USER
5.3 MARKET DYNAMICS
5.3.1 DRIVERS
5.3.1.1 Increasing adoption of personalized medicine
5.3.1.2 Growing applications of biochips
5.3.1.3 Technological advancements
5.3.2 RESTRAINTS
5.3.2.1 Unclear regulatory guidelines
5.3.2.2 High instrumentation costs
5.3.2.3 Absolute quantification of specific mRNA expressions
5.3.3 OPPORTUNITIES
5.3.3.1 Significant growth prospects in developing countries
5.3.3.2 Biochip technology, a safe and economical alternative to animal testing
5.3.4 CHALLENGES
5.3.4.1 Complexity of biological systems
6 BIOCHIPS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 DNA CHIPS
6.2.1 DNA CHIPS MARKET, BY APPLICATION
6.2.1.1 Gene expression
6.2.1.2 SNP Genotyping
6.2.1.3 Cancer Diagnosis & Treatment
6.2.1.4 Genomics
6.2.1.5 Drug Discovery
6.2.1.6 Agricultural Biotechnology
6.2.1.7 Other DNA Chip Applications
6.3 LAB-ON-A-CHIP
6.3.1 LAB-ON-A-CHIP MARKET, BY APPLICATION
6.3.1.1 Clinical Diagnostics
6.3.1.2 Genomics
6.3.1.3 IVD & POC
6.3.1.4 Proteomics
6.3.1.5 Drug Discovery
6.3.1.6 Other LOAC Applications Market
6.4 PROTEIN CHIPS
6.4.1 PROTEIN CHIPS MARKET, BY APPLICATIONS
6.4.1.1 Proteomics
6.4.1.2 Expression Profiling
6.4.1.3 Diagnostics
6.4.1.4 High-throughput Screening
6.4.1.5 Drug Discovery
6.4.1.6 Other Applications
6.5 OTHER ARRAYS
6.5.1 CELL ARRAYS
6.5.2 TISSUE ARRAYS
7 BIOCHIPS MARKET, BY FABRICATION TECHNOLOGY
7.1 INTRODUCTION
7.2 MICROARRAYS
7.3 MICROFLUIDICS
8 BIOCHIPS MARKET, BY END USER
8.1 INTRODUCTION
8.2 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
8.3 HOSPITALS AND DIAGNOSTICS CENTERS
8.4 ACADEMIC & RESEARCH INSTITUTES
8.5 OTHERS
9 BIOCHIPS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.3 EUROPE
9.4 ASIA-PACIFIC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE SITUATION AND TRENDS
10.2.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.2.2 ACQUISITIONS
10.2.3 PRODUCT LAUNCHES AND ENHANCEMENTS
10.2.4 EXPANSIONS
10.2.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Overview, Financial*, Products & Services, Strategy, and Developments)
11.1 INTRODUCTION
11.2 ABBOTT LABORATORIES
11.3 AGILENT TECHNOLOGIES, INC.
11.4 PERKINELMER, INC.
11.6 FLUIDIGM CORPORATION
11.7 ILLUMINA, INC.
11.8 GE HEALTHCARE
11.9 BIO-RAD LABORATORIES INC.
11.10 CEPHEID INC.
11.12 THERMO FISHER SCIENTIFIC, INC.
11.13 ROCHE DIAGNOSTICS
*Details might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
LIST OF TABLES
Table 1 INCREASING ADOPTION OF PERSONALIZED MEDICINE, A KEY DRIVER FOR THE GROWTH OF THE BIOCHIPS MARKET
Table 2 REGULATORY HURDLES TO LIMIT MARKET GROWTH DURING THE FORECAST PERIOD
Table 3 LUCRATIVE OPPORTUNITIES IN DEVELOPING COUNTRIES MAY BOOST MARKET GROWTH
Table 4 COMPLEXITY OF BIOLOGICAL SYSTEMS MAY HAMPER THE GROWTH OF THE MARKET
Table 5 BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 6 DNA CHIPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 7 DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 8 GENE EXPRESSION MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 9 SNP GENOTYPING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 10 CANCER DIAGNOSIS AND TREATMENT MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 11 GENOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 12 DRUG DISCOVERY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 13 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 14 OTHER DNA CHIP APPLICATIONS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 15 LAB-ON-A-CHIP MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 16 LAB-ON-A-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 17 CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 18 GENOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 19 IVD AND POC MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 20 PROTEOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 21 DRUG DISCOVERY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 22 OTHER LOC SYSTEMS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 23 PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 24 PROTEIN CHIPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 25 PROTEOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 26 EXPRESSION PROFILING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 27 DIAGNOSTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 28 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 29 DRUG DISCOVERY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 30 OTHER PROTEIN MICROARRAY APPLICATIONS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 31 OTHER ARRAYS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 32 OTHER ARRAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 33 CELL ARRAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 34 TISSUE ARRAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 35 BIOCHIP MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 36 MICROARRAYS IN BIOCHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
Table 37 MICROFLUIDICS IN BIOCHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
Table 38 BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 39 BIOCHIPS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2013–2020 (USD MILLION)
Table 40 BIOCHIPS MARKET SIZE FOR HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 41 BIOCHIPS MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2013–2020 (USD MILLION)
Table 42 BIOCHIPS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013–2020 (USD MILLION)
Table 43 BIOCHIPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 44 NORTH AMERICA: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 45 NORTH AMERICA: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 46 NORTH AMERICA: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 47 NORTH AMERICA: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 48 NORTH AMERICA: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 49 NORTH AMERICA: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 50 NORTH AMERICA: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 51 EUROPE: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 52 EUROPE: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 53 EUROPE: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 54 EUROPE: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 55 EUROPE: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 56 EUROPE: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 57 EUROPE: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 58 ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 59 ASIA-PACIFIC: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 60 ASIA-PACIFIC: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 61 ASIA-PACIFIC: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 62 ASIA-PACIFIC: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 63 ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 64 ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 65 ROW: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 66 ROW: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 67 ROW: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 68 ROW: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 69 ROW: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 70 ROW: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 71 ROW: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 72 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016
Table 73 ACQUISITIONS, 2013-2015
Table 74 PRODUCT LAUNCHES AND ENHANCEMENTS, 2013–2015
Table 75 EXPANSIONS, 2013–2015
Table 76 OTHER DEVELOPMENTS, 2013–2015
Table 1 INCREASING ADOPTION OF PERSONALIZED MEDICINE, A KEY DRIVER FOR THE GROWTH OF THE BIOCHIPS MARKET
Table 2 REGULATORY HURDLES TO LIMIT MARKET GROWTH DURING THE FORECAST PERIOD
Table 3 LUCRATIVE OPPORTUNITIES IN DEVELOPING COUNTRIES MAY BOOST MARKET GROWTH
Table 4 COMPLEXITY OF BIOLOGICAL SYSTEMS MAY HAMPER THE GROWTH OF THE MARKET
Table 5 BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 6 DNA CHIPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 7 DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 8 GENE EXPRESSION MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 9 SNP GENOTYPING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 10 CANCER DIAGNOSIS AND TREATMENT MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 11 GENOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 12 DRUG DISCOVERY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 13 AGRICULTURAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 14 OTHER DNA CHIP APPLICATIONS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 15 LAB-ON-A-CHIP MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 16 LAB-ON-A-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 17 CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 18 GENOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 19 IVD AND POC MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 20 PROTEOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 21 DRUG DISCOVERY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 22 OTHER LOC SYSTEMS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 23 PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 24 PROTEIN CHIPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 25 PROTEOMICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 26 EXPRESSION PROFILING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 27 DIAGNOSTICS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 28 HIGH-THROUGHPUT SCREENING MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 29 DRUG DISCOVERY MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 30 OTHER PROTEIN MICROARRAY APPLICATIONS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 31 OTHER ARRAYS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 32 OTHER ARRAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 33 CELL ARRAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 34 TISSUE ARRAYS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 35 BIOCHIP MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 36 MICROARRAYS IN BIOCHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
Table 37 MICROFLUIDICS IN BIOCHIPS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
Table 38 BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 39 BIOCHIPS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2013–2020 (USD MILLION)
Table 40 BIOCHIPS MARKET SIZE FOR HOSPITALS & DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 41 BIOCHIPS MARKET SIZE FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2013–2020 (USD MILLION)
Table 42 BIOCHIPS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013–2020 (USD MILLION)
Table 43 BIOCHIPS MARKET SIZE, BY REGION, 2013–2020 (USD MILLION)
Table 44 NORTH AMERICA: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 45 NORTH AMERICA: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 46 NORTH AMERICA: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 47 NORTH AMERICA: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 48 NORTH AMERICA: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 49 NORTH AMERICA: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 50 NORTH AMERICA: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 51 EUROPE: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 52 EUROPE: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 53 EUROPE: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 54 EUROPE: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 55 EUROPE: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 56 EUROPE: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 57 EUROPE: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 58 ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 59 ASIA-PACIFIC: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 60 ASIA-PACIFIC: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 61 ASIA-PACIFIC: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 62 ASIA-PACIFIC: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 63 ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 64 ASIA-PACIFIC: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 65 ROW: BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 66 ROW: OTHER BIOCHIPS MARKET SIZE, BY TYPE, 2013–2020 (USD MILLION)
Table 67 ROW: DNA CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 68 ROW: LAB-ON-CHIP MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 69 ROW: PROTEIN CHIPS MARKET SIZE, BY APPLICATION, 2013–2020 (USD MILLION)
Table 70 ROW: BIOCHIPS MARKET SIZE, BY FABRICATION TECHNOLOGY, 2013–2020 (USD MILLION)
Table 71 ROW: BIOCHIPS MARKET SIZE, BY END USER, 2013–2020 (USD MILLION)
Table 72 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016
Table 73 ACQUISITIONS, 2013-2015
Table 74 PRODUCT LAUNCHES AND ENHANCEMENTS, 2013–2015
Table 75 EXPANSIONS, 2013–2015
Table 76 OTHER DEVELOPMENTS, 2013–2015
LIST OF FIGURES
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION AND DATA TRIANGULATION
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY
Figure 4 BIOCHIPS MARKET SNAPSHOT, 2015 VS. 2020
Figure 5 DNA CHIPS SEGMENT WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET IN 2020
Figure 6 MICROFLUIDICS SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
Figure 7 HOSPITALS AND DIAGNOSTICS CENTERS SEGMENT DOMINATED THE BIOCHIPS END-USER MARKET IN 2015
Figure 8 GEOGRAPHICAL SNAPSHOT OF THE BIOCHIPS MARKET, 2015
Figure 9 INCREASED ADOPTION OF PERSONALISED MEDICINE TO DRIVE THE BIOCHIPS MARKET GROWTH DURING THE FORECAST PERIOD
Figure 10 DNA CHIPS TO DOMINATE THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 11 ASIA-PACIFIC TO REGISTER HIGHEST GROWTH FROM 2015 TO 2020
Figure 12 LAB-ON-A-CHIP SEGMENT TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020
Figure 13 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE THE BIOCHIPS END-USER MARKET IN 2015
Figure 14 HIGH GROWTH POTENTIAL IN THE MICROFLUIDICS FABRICATION TECHNOLOGY MARKET
Figure 15 BIOCHIPS MARKET SEGMENTATION, BY TYPE AND APPLICATION
Figure 16 BIOCHIPS MARKET SEGMENTATION, BY FABRICATION TECHNOLOGY
Figure 17 BIOCHIPS MARKET SEGMENTATION, BY END USER
Figure 18 BIOCHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
Figure 19 ONCOLOGY TREATMENT OPTIONS MARKET SHARE, 2003 VS. 2013
Figure 20 LOCAL VS. MULTINATIONAL CLINICAL STUDIES, 2015
Figure 21 DNA BIOCHIPS ACCOUNTED FOR THE LARGEST SHARE OF THE OVERALL BIOCHIPS MARKET, BY TYPE, IN 2015
Figure 22 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE OVERALL DNA CHIPS MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 23 CANCER DIAGNOSIS AND TREATMENT ACCOUNTED FOR THE LARGEST SHARE OF DNA CHIPS MARKET, BY APPLICATION, IN 2015
Figure 24 ASIA-PACIFIC IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE IN THE GENE EXPRESSION MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 25 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE SNP GENOTYPING MARKET DURING THE FORECAST PERIOD
Figure 26 ASIA-PACIFIC IS EXPECTED TO ACCOUNT FOR HIGHEST GROWTH RATE OF THE CANCER DIAGNOSIS AND TREATMENT MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 27 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE GENOMICS MARKET, BY TYPE, IN 2015
Figure 28 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE DRUG DISCOVERY MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 29 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE AGRICULTURE BIOTECHNOLOGY MARKET, BY APPLICATION, DURING THE FORECAST PERIOD
Figure 30 CLINICAL DIAGNOSTICS ACCOUNTED FOR THE LARGEST SHARE OF THE LAB-ON-A-CHIP MARKET, BY APPLICATION, IN 2015
Figure 31 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE CLINICAL DIAGNOSTICS MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 32 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE GENOMICS MARKET, BY REGION, IN 2015
Figure 33 ASIA-PACIFIC TO REGISTER HIGHEST GROWTH IN THE IVD AND POC MARKET, BY REGION DURING THE FORECAST PERIOD
Figure 34 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE PROTEOMICS MARKET, BY REGION, IN 2015
Figure 35 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE DRUG DISCOVERY MARKET, BY REGION DURING THE FORECAST PERIOD
Figure 36 PROTEOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE PROTEIN CHIPS MARKET, BY APPLICATION, IN 2015
Figure 37 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE PROTEOMICS MARKET, BY REGION, IN 2015
Figure 38 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE EXPRESSION PROFILING MARKET DURING THE FORECAST PERIOD
Figure 39 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE DIAGNOSTICS MARKET, BY REGION, IN 2015
Figure 40 ASIA-PACIFIC MARKET WILL REGISTER THE FASTEST GROWTH IN THE HTS MARKET DURING THE FORECAST PERIOD
Figure 41 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE DRUG DISCOVERY MARKET, BY REGION, IN 2015
Figure 42 TISSUE ARRAYS ACCOUNTED FOR THE LARGEST SHARE OF THE OVERALL OTHER ARRAYS MARKET, BY TYPE, IN 2015
Figure 43 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE OTHER ARRAYS MARKET DURING THE FORECAST PERIOD
Figure 44 MICROARRAYS WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET IN 2020
Figure 45 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF MICROARRAYS MARKET IN 2015
Figure 46 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH IN MICROFLUIDICS IN BIOCHIPS MARKET
Figure 47 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE MAJOR END USERS OF THE BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 48 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES DURING THE FORECAST PERIOD
Figure 49 ASIA-PACIFIC OFFERS LUCRATIVE GROWTH OPPORTUNITIES FOR BIOCHIPS MARKET FOR HOSPITALS AND DIAGNOSTICS CENTERS DURING THE FORECAST PERIOD
Figure 50 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE OTHER END USERS MARKET IN 2015
Figure 51 GEOGRAPHIC SNAPSHOT: ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGION IN THE BIOCHIPS MARKET BY 2020
Figure 52 ASIA-PACIFIC MARKET FOR BIOCHIPS SHOWS SIGNIFICANT GROWTH OPPORTUNITIES
Figure 53 NORTH AMERICA WILL CONTINUE TO LEAD THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 54 NORTH AMERICA: BIOCHIPS MARKET SNAPSHOT 2015-2020
Figure 55 GENE EXPRESSION SEGMENT TO SHOW HIGHEST GROWTH IN THE NORTH AMERICAN DNA CHIPS MARKET DURING THE FORECAST PERIOD
Figure 56 PROTEOMICS WILL CONTINUE TO LEAD THE NORTH AMERICAN PROTEIN CHIPS MARKET DURING THE FORECAST PERIOD
Figure 57 HOSPITAL AND DIAGNOSTICS CENTERS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 58 DNA CHIPS WILL CONTINUE TO DOMINATE THE EUROPEAN BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 59 GENE EXPRESSION APPLICATION SEGMENT OF THE EUROPEAN DNA CHIPS MARKET IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 60 HOSPITAL AND DIAGNOSTICS CENTERS END-USER SEGMENT WILL CONTINUE TO DOMINATE THE EUROPEAN MARKET DURING THE FORECAST PERIOD
Figure 61 ASIA-PACIFIC BIOCHIPS MARKET SNAPSHOT 2015-2020
Figure 62 GENE EXPRESSION SEGMENT WILL CONTINUE TO LEAD THE ASIA-PACIFIC DNA CHIPS MARKET DURING THE FORECAST PERIOD
Figure 63 PROTEOMICS HOLDS HIGHEST SHARE IN THE ASIA-PACIFIC PROTEIN CHIPS MARKET IN 2015
Figure 64 HOSPITAL AND DIAGNOSTICS CENTERS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 65 DNA CHIPS WILL CONTINUE TO HOLD THE HIGHEST SHARE IN THE ROW BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 66 HOSPITAL AND DIAGNOSTICS CENTERS WILL CONTINUE TO LEAD THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 67 ACQUISITIONS & AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN 2013-2016
Figure 68 ACQUISITIONS & AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS—KEY GROWTH STRATEGIES ADOPTED BY PLAYERS IN BIOCHIPS MARKET
Figure 69 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS
Figure 1 RESEARCH DESIGN
Figure 2 MARKET SIZE ESTIMATION AND DATA TRIANGULATION
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY
Figure 4 BIOCHIPS MARKET SNAPSHOT, 2015 VS. 2020
Figure 5 DNA CHIPS SEGMENT WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET IN 2020
Figure 6 MICROFLUIDICS SEGMENT TO WITNESS THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
Figure 7 HOSPITALS AND DIAGNOSTICS CENTERS SEGMENT DOMINATED THE BIOCHIPS END-USER MARKET IN 2015
Figure 8 GEOGRAPHICAL SNAPSHOT OF THE BIOCHIPS MARKET, 2015
Figure 9 INCREASED ADOPTION OF PERSONALISED MEDICINE TO DRIVE THE BIOCHIPS MARKET GROWTH DURING THE FORECAST PERIOD
Figure 10 DNA CHIPS TO DOMINATE THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 11 ASIA-PACIFIC TO REGISTER HIGHEST GROWTH FROM 2015 TO 2020
Figure 12 LAB-ON-A-CHIP SEGMENT TO GROW AT THE HIGHEST RATE FROM 2015 TO 2020
Figure 13 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE THE BIOCHIPS END-USER MARKET IN 2015
Figure 14 HIGH GROWTH POTENTIAL IN THE MICROFLUIDICS FABRICATION TECHNOLOGY MARKET
Figure 15 BIOCHIPS MARKET SEGMENTATION, BY TYPE AND APPLICATION
Figure 16 BIOCHIPS MARKET SEGMENTATION, BY FABRICATION TECHNOLOGY
Figure 17 BIOCHIPS MARKET SEGMENTATION, BY END USER
Figure 18 BIOCHIPS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
Figure 19 ONCOLOGY TREATMENT OPTIONS MARKET SHARE, 2003 VS. 2013
Figure 20 LOCAL VS. MULTINATIONAL CLINICAL STUDIES, 2015
Figure 21 DNA BIOCHIPS ACCOUNTED FOR THE LARGEST SHARE OF THE OVERALL BIOCHIPS MARKET, BY TYPE, IN 2015
Figure 22 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE OVERALL DNA CHIPS MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 23 CANCER DIAGNOSIS AND TREATMENT ACCOUNTED FOR THE LARGEST SHARE OF DNA CHIPS MARKET, BY APPLICATION, IN 2015
Figure 24 ASIA-PACIFIC IS EXPECTED TO REGISTER THE HIGHEST GROWTH RATE IN THE GENE EXPRESSION MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 25 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE SNP GENOTYPING MARKET DURING THE FORECAST PERIOD
Figure 26 ASIA-PACIFIC IS EXPECTED TO ACCOUNT FOR HIGHEST GROWTH RATE OF THE CANCER DIAGNOSIS AND TREATMENT MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 27 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE GENOMICS MARKET, BY TYPE, IN 2015
Figure 28 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE DRUG DISCOVERY MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 29 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE AGRICULTURE BIOTECHNOLOGY MARKET, BY APPLICATION, DURING THE FORECAST PERIOD
Figure 30 CLINICAL DIAGNOSTICS ACCOUNTED FOR THE LARGEST SHARE OF THE LAB-ON-A-CHIP MARKET, BY APPLICATION, IN 2015
Figure 31 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE CLINICAL DIAGNOSTICS MARKET, BY REGION, DURING THE FORECAST PERIOD
Figure 32 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE GENOMICS MARKET, BY REGION, IN 2015
Figure 33 ASIA-PACIFIC TO REGISTER HIGHEST GROWTH IN THE IVD AND POC MARKET, BY REGION DURING THE FORECAST PERIOD
Figure 34 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE PROTEOMICS MARKET, BY REGION, IN 2015
Figure 35 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE DRUG DISCOVERY MARKET, BY REGION DURING THE FORECAST PERIOD
Figure 36 PROTEOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE PROTEIN CHIPS MARKET, BY APPLICATION, IN 2015
Figure 37 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE PROTEOMICS MARKET, BY REGION, IN 2015
Figure 38 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE EXPRESSION PROFILING MARKET DURING THE FORECAST PERIOD
Figure 39 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE DIAGNOSTICS MARKET, BY REGION, IN 2015
Figure 40 ASIA-PACIFIC MARKET WILL REGISTER THE FASTEST GROWTH IN THE HTS MARKET DURING THE FORECAST PERIOD
Figure 41 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE DRUG DISCOVERY MARKET, BY REGION, IN 2015
Figure 42 TISSUE ARRAYS ACCOUNTED FOR THE LARGEST SHARE OF THE OVERALL OTHER ARRAYS MARKET, BY TYPE, IN 2015
Figure 43 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE IN THE OTHER ARRAYS MARKET DURING THE FORECAST PERIOD
Figure 44 MICROARRAYS WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET IN 2020
Figure 45 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF MICROARRAYS MARKET IN 2015
Figure 46 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH IN MICROFLUIDICS IN BIOCHIPS MARKET
Figure 47 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE MAJOR END USERS OF THE BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 48 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOCHIPS MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES DURING THE FORECAST PERIOD
Figure 49 ASIA-PACIFIC OFFERS LUCRATIVE GROWTH OPPORTUNITIES FOR BIOCHIPS MARKET FOR HOSPITALS AND DIAGNOSTICS CENTERS DURING THE FORECAST PERIOD
Figure 50 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE OF THE OTHER END USERS MARKET IN 2015
Figure 51 GEOGRAPHIC SNAPSHOT: ASIA-PACIFIC WILL BE THE FASTEST-GROWING REGION IN THE BIOCHIPS MARKET BY 2020
Figure 52 ASIA-PACIFIC MARKET FOR BIOCHIPS SHOWS SIGNIFICANT GROWTH OPPORTUNITIES
Figure 53 NORTH AMERICA WILL CONTINUE TO LEAD THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 54 NORTH AMERICA: BIOCHIPS MARKET SNAPSHOT 2015-2020
Figure 55 GENE EXPRESSION SEGMENT TO SHOW HIGHEST GROWTH IN THE NORTH AMERICAN DNA CHIPS MARKET DURING THE FORECAST PERIOD
Figure 56 PROTEOMICS WILL CONTINUE TO LEAD THE NORTH AMERICAN PROTEIN CHIPS MARKET DURING THE FORECAST PERIOD
Figure 57 HOSPITAL AND DIAGNOSTICS CENTERS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 58 DNA CHIPS WILL CONTINUE TO DOMINATE THE EUROPEAN BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 59 GENE EXPRESSION APPLICATION SEGMENT OF THE EUROPEAN DNA CHIPS MARKET IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 60 HOSPITAL AND DIAGNOSTICS CENTERS END-USER SEGMENT WILL CONTINUE TO DOMINATE THE EUROPEAN MARKET DURING THE FORECAST PERIOD
Figure 61 ASIA-PACIFIC BIOCHIPS MARKET SNAPSHOT 2015-2020
Figure 62 GENE EXPRESSION SEGMENT WILL CONTINUE TO LEAD THE ASIA-PACIFIC DNA CHIPS MARKET DURING THE FORECAST PERIOD
Figure 63 PROTEOMICS HOLDS HIGHEST SHARE IN THE ASIA-PACIFIC PROTEIN CHIPS MARKET IN 2015
Figure 64 HOSPITAL AND DIAGNOSTICS CENTERS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
Figure 65 DNA CHIPS WILL CONTINUE TO HOLD THE HIGHEST SHARE IN THE ROW BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 66 HOSPITAL AND DIAGNOSTICS CENTERS WILL CONTINUE TO LEAD THE GLOBAL BIOCHIPS MARKET DURING THE FORECAST PERIOD
Figure 67 ACQUISITIONS & AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN 2013-2016
Figure 68 ACQUISITIONS & AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS—KEY GROWTH STRATEGIES ADOPTED BY PLAYERS IN BIOCHIPS MARKET
Figure 69 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS
